https://www.selleckchem.com/pr....oducts/cerivastatin-
7% vs. 11.7%) and in periods 1 and 3 (9.7 vs. 11.8%). The percentage of patients treated with IVT during the pandemic (22.4%) did not differ from period 2 (20.0%) or period 3 (21.4%). No difference was found in the rate of MT between the COVID-19 period (10.2%) and the same period in 2019 (10.7%) and in January to February 2020 (13.1%). The median DNT remained unchanged in periods 1 (30min), 2 (35min) and 3 (30min), and no differences were found in median ONT in periods 1 (130min), 2 (130min) and 3 (140min). We found a decre
Gefällt mir
Kommentar
Teilen
